Nationwide Fund Advisors - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 69 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 4.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationwide Fund Advisors ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2014$131,000
+33.7%
11,106
-5.3%
0.00%
Q4 2013$98,000
-10.1%
11,7240.0%0.00%
Q3 2013$109,000
-1.8%
11,724
+3.7%
0.00%
-100.0%
Q2 2013$111,00011,3040.00%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
Abingworth LLP 396,104$400,0000.42%
Ancora Advisors LLC 50,865$51,0000.01%
EAGLE GLOBAL ADVISORS LLC 145,710$146,0000.00%
Acrospire Investment Management LLC 5,200$5,0000.00%
A.R.T. Advisors, LLC 57,954$57,0000.00%
Renaissance Technologies 876,100$876,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 4,600$5,0000.00%
Cutler Group LLC / CA 11,048$11,0000.00%
PANAGORA ASSET MANAGEMENT INC 133,846$134,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$46,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders